The FWGBD Case Conversation Series will feature case-based presentations and discussion by leading experts in the areas of hematology and reproductive health on the diagnosis, treatment and management of blood disorders affecting women and girls across the lifespan. This virtual series will also offer a special emphasis on the ways in which collaboration between key specialists (i.e., hematology and reproductive health) augments management.
The principal goals of this virtual forum are to: (a) enhance participants’ understanding of the current state of knowledge; (b) utilize current cases to shape the discussion; (c) provide an overview of evidence-based, practical information as well as new, effective approaches to the diagnosis, testing, and assessment of disorders affecting women and girls; and (d) provide experience in reviewing and critiquing research. Each session will feature recent key articles to support the discussion. All registrants will receive a copy of the selected journal articles in advance.
Case Conversation: Contraceptive Use and Preferences in Females with Sickle Cell Disease
10/29/2021 12:00 pm-1:00 pm ET
Women with sickle cell disease are now living longer – and having more babies – than ever before. Given the high rate of pregnancy complications in women with sickle cell disease, contraception is a crucial part of optimal health care. In this study, patients with sickle cell disease were surveyed about their contraceptive usage and preferences. The survey results identified that women with sickle cell disease are less likely to use contraception, and use different kinds of contraception, than the general US population. In this session, the presenters will illustrate the limitations in providing optimal patient care due to the need for research on contraception usage and decision-making, and in turn, will provide strategies to discussing contraception that will lead to improved patient health.
In the second of FWGBD's Case Conversation series, our expert faculty, Dr. Andrea Roe and Dr. Tami Chrisentery-Singleton, will review the upcoming journal article, "Contraceptive use and preferences among females with sickle cell disease," and will review the usage and preferences of contraceptives in women and girls with sickle cell disease. Dr. Roe is the first author on the article. The case presentations and discussion will be followed by an interactive Q & A session with participants.
To register, please visit https://attendee.gotowebinar.com/register/8081366901587691788.
Andrea Roe, MD, MPH
Assistant Professor of Obstetrics and Gynecology
Tammuella Chrisentery-Singleton, MD
Director, Hemophilia Treatment Center
Chief, Pediatric Hematology
Mississippi Center for Advanced Medicine (MCAM)
Louisiana Center for Advanced Medicine (LCAM)
Case Conversation: New Developments in Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
8/25/2021 1:00 pm-2:00 pm ET
This is a recorded version of the first Case Conversation: New Developments in Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT). This program was presented by Dr. Jim Bussel and Dr. Emilie Vander Haar, and was moderated by Dr. Andra James and Kim Roque. It took place on August 25, 2021. The production and archiving of this program were made possible in part by an educational grant from Janssen. If you would like to obtain CME credits for this webinar, please contact Kim Roque.